Stock Rating Upgrade
Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Puma Biotechnology Inc (NASDAQ: PBYI) improved during the last several trading days. PBYI’s current Value Trend Rating is B and the prior Rating was C. Details supporting this higher rating are included in our next report.
Recent Price Action
Puma Biotechnology Inc (NASDAQ: PBYI) stock declined by -2.4% on 5/1/24. The shares closed at $4.95. However, exceptionally low trading volume at 47% of normal accompanied the decline. The stock has been exceptionally strong relative to the market over the last nine months but has declined -3.5% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be above the cost of capital, PBYI is expected to continue to be a major Value Builder.
Puma Biotechnology has a current Value Trend Rating of B (Positive). This VT Rating improved in recent days from C previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. Puma Biotechnology has a neutral Appreciation Score of 48 but a very high Power Rating of 90, with the Positive Value Trend Rating the result.
Be the first to comment